Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
27
Number of overlapping holdings
37.5%
% of CNCR's 72 holdings also in CANC
56.3%
% of CANC's 48 holdings also in CNCR
Overlap by Weight
Sector Drift (CNCR minus CANC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CNCR |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
EXELIXIS INC | 2.7% | 4.0% | 2.7% |
|
BRISTOL-MYERS SQUIBB CO | 2.4% | 4.5% | 2.4% |
|
BLUEPRINT MEDICINES CORP. | 2.1% | 2.9% | 2.1% |
 |
MERUS N.V. | 1.8% | 3.1% | 1.8% |
|
ARCELLX, INC. | 1.8% | 3.0% | 1.8% |
Position Highlights (Non-Overlapping Exposures)
CNCR Overweight Relative to CANC
|
RECURSION PHARMACEUTICALS, INC CLASS | 3.6% |
|
INTREXON CORP | 3.2% |
|
SPRINGWORKS THERAPEUTICS, INC. | 2.7% |
|
GENELUX CORP. | 2.5% |
|
COMPASS THERAPEUTICS, INC. | 2.4% |
|
2SEVENTY BIO, INC. | 2.1% |
|
GINKGO BIOWORKS HOLDINGS INC CLASS A | 2.0% |
 |
HUTCHISON CHINA MEDITECH LIMITED SPO | 1.9% |
|
MONTE ROSA THERAPEUTICS, INC. | 1.8% |
|
IMMUNITYBIO INC | 1.8% |
CNCR Underweight Relative to CANC
|
ELI LILLY & CO | -5.3% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | -5.2% |
|
ASTRAZENECA PLC | -4.3% |
|
NOVARTIS AG | -4.2% |
|
BRIDGEBIO PHARMA, INC. | -4.1% |
|
REVOLUTION MEDICINES, INC. | -3.7% |
 |
ZAI LAB LTD. UNSPONSORED ADR | -3.7% |
 |
DAIICHI SANKYO CO LTD | -3.0% |
|
BEIGENE LTD. SPONSORED ADR | -2.9% |
|
AMGEN INC | -2.9% |